Switch to:
More From Other Websites
CEL SCI CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jul 22 2016
ETF’s with exposure to CEL-SCI Corp. : July 20, 2016 Jul 20 2016
NEW STORY CEL-SCI Granted European Patent for Multikine Cancer Immunotherapy in Combination with... Jul 11 2016
CEL-SCI Granted European Patent for Multikine Cancer Immunotherapy in Combination with Radiation... Jul 11 2016
NEW STORY CEL-SCI Reports Monthly Patient Enrollment in June for Its Phase 3 Head and Neck Cancer... Jul 05 2016
CEL-SCI Reports Monthly Patient Enrollment in June for Its Phase 3 Head and Neck Cancer Trial Jul 05 2016
Why Registered Direct Offerings Are Like Insider Proxies, 3 Stocks in Point Jun 27 2016
NEW STORY CEL-SCI to Present at LD Micro Invitational Jun 07 2016
CEL-SCI to Present at LD Micro Invitational Jun 07 2016
NEW STORY CEL-SCI Reports Monthly Patient Enrollment in May for Its Phase 3 Head and Neck Cancer... Jun 01 2016
CEL-SCI Reports Monthly Patient Enrollment in May for Its Phase 3 Head and Neck Cancer Trial Jun 01 2016
NEW STORY CEL-SCI to Present At the Fifth Annual Marcum Microcap Conference May 31 2016
CEL-SCI to Present at the Fifth Annual Marcum MicroCap Conference May 31 2016
NEW STORY CEL-SCI Announces the Closing of Its $5 Million Registered Direct Offering May 24 2016
CEL-SCI Announces the Closing of Its $5 Million Registered Direct Offering May 24 2016
CEL SCI CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements... May 19 2016
CEL SCI CORP Financials May 19 2016
CEL-SCI Corp. :CVM-US: Earnings Analysis: Q2, 2016 By the Numbers May 18 2016
NEW STORY CEL-SCI Announces $5 Million Registered Direct Offering May 18 2016
CEL-SCI Announces $5 Million Registered Direct Offering May 18 2016
Cel-Sci reports 2Q loss May 10 2016
Cel-Sci reports 2Q loss May 10 2016
NEW STORY CEL-SCI Corporation Reports Second Quarter Fiscal Year 2016 Financial Results May 10 2016
CEL-SCI Corporation Reports Second Quarter Fiscal Year 2016 Financial Results May 10 2016
CEL SCI CORP Files SEC form 10-Q, Quarterly Report May 10 2016
NEW STORY CEL-SCI Reports Record Monthly Patient Enrollment in April for Its Phase 3 Head and Neck... May 02 2016
CEL-SCI Reports Record Monthly Patient Enrollment in April for Its Phase 3 Head and Neck Cancer... May 02 2016
CEL-SCI's Manufacturing of Cancer Killer Multikine Marks a World-Class Facility Apr 14 2016
CEL-SCI Corporation (NYSE MKT: CVM) is Selected as Bob Flaherty's Personal Pick in Flaherty's 35th... Apr 13 2016
NEW STORY CEL-SCI Featured on The RedChip Money Report Airing on Newsmax TV Apr 08 2016
CEL-SCI Featured on The RedChip Money Report Airing on Newsmax TV Apr 08 2016
NEW STORY CEL-SCI Reports Monthly Patient Enrollment in March for Its Phase 3 Head and Neck Cancer... Apr 01 2016
CEL-SCI Reports Monthly Patient Enrollment in March for Its Phase 3 Head and Neck Cancer Trial Apr 01 2016
CEL-SCI Corporation's (NYSE: CVM) Global Phase III Cancer Immunotherapy Progress is Updated in... Mar 10 2016
Cel-Sci posts 1Q profit Feb 09 2016
NEW STORY CEL-SCI Reports Monthly Patient Enrollment in January for Its Phase 3 Head and Neck Cancer... Feb 01 2016
NEW STORY CEL-SCI'S Chief Scientific Officer Discusses Cancer Immunotherapy Multikine Jan 25 2016
NEW STORY CEL-SCI Corporation to Present at the Noble Financial Capital Markets' 12th Annual... Jan 14 2016
NEW STORY CEL-SCI Corporation Summarizes Significant Accomplishments in 2015 and Positive Momentum... Jan 08 2016
NEW STORY CEL-SCI Reports Record Year for Patient Enrollment With 75% Increase in Its Global Phase 3... Jan 05 2016
Cel-Sci reports 4Q loss Dec 11 2015
NEW STORY CEL-SCI Reports Fiscal 2015 Financial Results and Clinical & Corporate Developments Dec 11 2015
NEW STORY CEL-SCI's CEO Presentation Available On Company Website Dec 04 2015
NEW STORY CEL-SCI Reports Monthly Patient Enrollment in November for Its Phase 3 Head and Neck... Dec 01 2015
NEW STORY CEL-SCI Corporation To Present At The LD Micro Main Event Nov 30 2015
Cel-Sci reports 3Q loss Aug 07 2015
Cel-Sci reports 2Q loss May 08 2015

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK